Literature DB >> 11291770

Cyclooxygenase-1 and cyclooxygenase-2 expression in rat kidney and adrenal gland after stimulation with systemic lipopolysaccharide: in situ hybridization and immunocytochemical studies.

Y Ichitani1, K Holmberg, A B Maunsbach, J Z Haeggström, B Samuelsson, D De Witt, T Hökfelt.   

Abstract

Cyclooxygenase-2 (COX-2) is a recently discovered isoform of cyclooxygenase that is inducible by various types of inflammatory stimuli. Although this enzyme is considered to play a major role in inflammation processes by catalyzing the production of prostaglandins, the precise location, distribution, and regulation of prostaglandin synthesis remains unclear in several tissues. Using in situ hybridization histochemistry, we investigated the induction of COX-1 and COX-2 mRNA expression after systemic administration of a pyrogen, lipopolysaccharide (LPS), in kidney and adrenal gland in the rat. The COX-2 mRNA signals dramatically increased 1 h after LPS treatment in the kidney outer medulla and adrenal cortex, where almost no or little expression was observed in nontreated animals, and returned to control levels within 24 h. COX-2 mRNA levels increased in the kidney inner medulla 6 h after treatment. There was also a significant increase in mRNA levels in the kidney cortex and adrenal medulla. On the other hand, COX-1 mRNA levels did not show any detectable changes except in the kidney inner medulla, where a significant downregulation of mRNA expression was observed after LPS treatment. Light and electron immunocytochemistry using COX-2 antibodies showed that strong COX-2 immunoreactivity was localized to certain cortical cells of the thick ascending limb of Henle. In addition, based on double-staining with antiserum to nitric oxide synthase (NOS) four further cell populations could be identified in kidney cortex, including weakly COX-2-positive, NOS-positive macula densa cells. After LPS treatment, changes in COX-2 immunoreactivity could be observed in interstitial cells in the kidney medulla and in inner cortical cells in the adrenal gland. These results show that COX-2 is a highly induced enzyme that can be up-regulated in specific cell populations in kidney and adrenal gland in response to inflammation, leading to the elevated levels of prostaglandins seen during fever. In contrast COX-1 mRNA levels remained unchanged in this experimental situation, except for a decrease in kidney inner medulla.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291770     DOI: 10.1007/s004410000296

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  15 in total

1.  Expression of COX-1 and COX-2 in a clinical model of acute inflammation.

Authors:  Asma A Khan; Michael Iadarola; Hsiu-Ying T Yang; Raymond A Dionne
Journal:  J Pain       Date:  2007-01-30       Impact factor: 5.820

2.  Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia.

Authors:  Sisi Liu; Emmanouil Saloustros; Annabel Berthon; Matthew F Starost; Isabelle Sahut-Barnola; Paraskevi Salpea; Eva Szarek; Fabio R Faucz; Antoine Martinez; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2015-10-05       Impact factor: 5.678

Review 3.  Eicosanoids and tumor necrosis factor-alpha in the kidney.

Authors:  Nicholas R Ferreri; Shoujin Hao; Paulina L Pedraza; Bruno Escalante; Carlos P Vio
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-11-11       Impact factor: 3.072

4.  Regulation of calcium channels and exocytosis in mouse adrenal chromaffin cells by prostaglandin EP3 receptors.

Authors:  Mark L Jewell; Richard M Breyer; Kevin P M Currie
Journal:  Mol Pharmacol       Date:  2011-03-07       Impact factor: 4.436

Review 5.  Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.

Authors:  Gary Noroian; David Clive
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies.

Authors:  Włodzimierz Matysiak; Barbara Jodłowska-Jedrych
Journal:  Protoplasma       Date:  2010-08-19       Impact factor: 3.356

7.  Differential regulation of renin and Cox-2 expression in the renal cortex of C57Bl/6 mice.

Authors:  Charlotte Wagner; Helga Vitzthum; Hayo Castrop; Karl Schumacher; Michael Bucher; Sybille Albertin; Thomas M Coffman; William J Arendshorst; Armin Kurtz
Journal:  Pflugers Arch       Date:  2003-09-19       Impact factor: 3.657

8.  Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland.

Authors:  Enrique Sanchez-Lemus; Yuki Murakami; Ignacio M Larrayoz-Roldan; Armen J Moughamian; Jaroslav Pavel; Tsuyoshi Nishioku; Juan M Saavedra
Journal:  Endocrinology       Date:  2008-06-12       Impact factor: 4.736

Review 9.  Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery.

Authors:  Julius Benicky; Enrique Sánchez-Lemus; Jaroslav Pavel; Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2009-03-04       Impact factor: 5.046

10.  Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions.

Authors:  Sarah Lambert-Langlais; Jean-Christophe Pointud; Anne-Marie Lefrançois-Martinez; Fanny Volat; Michèle Manin; François Coudoré; Pierre Val; Isabelle Sahut-Barnola; Bruno Ragazzon; Estelle Louiset; Catherine Delarue; Hervé Lefebvre; Yoshihiro Urade; Antoine Martinez
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.